EMERYVILLE, Calif., Sept. 16, 2016 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the Singular Research “Best of The Uncovereds” Conference to be held September 22, 2016, at the Luxe Sunset Boulevard Hotel in Los Angeles.
Amyris will provide an update on its business during the presentation, which is scheduled for Thursday, September 22, at 1:30 p.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com.
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are registered trademarks of Amyris, Inc.
Contact: Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 [email protected] [email protected]


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 



